Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients

Clinical trial NCT00138697 · COMPLETED

Trial details

NCT number: NCT00138697
Sponsor: Prothya Biosolutions
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hypogammaglobulinemia

Start date: 2001-05-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.